Eisenhofer G, Goldstein D S, Ropchak T G, Nguyen H Q, Keiser H R, Kopin I J
Clinical Neuroscience Branch, National Institute of Neurological and Communicative Disorders, and Stroke, Bethesda, MD 20892.
J Auton Nerv Syst. 1988 Sep;24(1-2):1-14. doi: 10.1016/0165-1838(88)90130-0.
To elucidate the source and physiological significance of plasma 3,4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG) as metabolites of noradrenaline (NA), unlabeled and tritium-labeled NA [( 3H]NA) were infused into conscious rats and the formation of labeled and unlabeled DHPG and MHPG examined. Animals were pretreated with clorgyline to determine the effects of inhibiting monoamine oxidase type A (MAO-A), with desipramine to determine the effects of blockade of NA neuronal uptake, or with reserpine to determine the effects of interference with vesicular translocation of NA. Inhibition of neuronal uptake prevented the formation of DHPG from exogenous NA and halved the formation of MHPG, indicating that DHPG is derived from NA metabolized intraneuronally and that MHPG is derived from NA metabolized extraneuronally and from DHPG produced intraneuronally. Blockade of vesicular translocation of NA with reserpine increased DHPG formation from exogenous NA by 300% and MHPG formation by 70%, consistent with enhanced availability of NA in the neuronal cytoplasm for metabolism by MAO-A. About 74% of NA recaptured by sympathetic nerves was estimated to be sequestered into storage vesicles. Endogenous DHPG and MHPG were derived mainly (60-70%) from leakage of NA from storage vesicles and to a smaller extent (30-40%) from NA recaptured after exocytotic release. An increased plasma DHPG to NA ratio with no change in the MHPG to NA ratio during infusions of physiologically active NA demonstrated that changes in plasma MHPG do not necessarily follow changes in DHPG. Consideration of the intra- and extraneuronal sources of plasma DHPG and MHPG, their main derivation from NA directly released into the neuronal cytoplasm and the influences of neuronal uptake and translocation of NA into storage vesicles is essential for the correct interpretation of plasma concentrations of these metabolites in the evaluation of sympathetic nervous function.
为阐明作为去甲肾上腺素(NA)代谢产物的血浆3,4 - 二羟基苯乙二醇(DHPG)和3 - 甲氧基 - 4 - 羟基苯乙二醇(MHPG)的来源及生理意义,将未标记和氚标记的NA [(³H]NA)注入清醒大鼠体内,并检测标记和未标记的DHPG及MHPG的生成情况。动物分别用氯吉兰预处理以确定抑制A型单胺氧化酶(MAO - A)的作用,用地昔帕明确定阻断NA神经元摄取的作用,或用利血平确定干扰NA囊泡转运的作用。抑制神经元摄取可阻止外源性NA生成DHPG,并使MHPG的生成减半,这表明DHPG源自神经元内代谢的NA,而MHPG源自神经元外代谢的NA以及神经元内生成的DHPG。利血平阻断NA的囊泡转运使外源性NA生成DHPG增加300%,生成MHPG增加70%,这与神经元胞质中可用于MAO - A代谢的NA可用性增强一致。据估计,交感神经重新摄取的NA约74%被隔离到储存囊泡中。内源性DHPG和MHPG主要(6% - 70%)源自储存囊泡中NA的泄漏,较小程度上(30% - 40%)源自胞吐释放后重新摄取的NA。在输注生理活性NA期间,血浆DHPG与NA的比值增加而MHPG与NA的比值无变化,这表明血浆MHPG变化不一定随DHPG变化。在评估交感神经功能时,考虑血浆DHPG和MHPG的神经元内和神经元外来源、它们主要源自直接释放到神经元胞质中的NA以及NA的神经元摄取和转运到储存囊泡中的影响,对于正确解释这些代谢产物的血浆浓度至关重要。